Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Université Laval

$30,000.00

Design, development and validation of a tunable antibacterial coating for spinal implants: Focus on biological performances through the NSERC-FRQNT NOVA Complement. _x000d_ _x000d_

FY 2020-21

Summary
Back pains are considered as the main cause of invalidity worldwide (Population Health Worldwide Statistic, 2018), which include minor disturbs (dorsal sprains) to normal wear of intervertebral discs or sciatic. Arthroses, as a disc degeneration, and osteoporosis, constitute the main cause of these clinical complications. Often treated early by manipulations, when the diseases progress, surgeries are which include the implantation of a rachis implant. Directly implanted into spine, evident challenges and clinical risks represent major factor to control for the success. These implants, made of Ti and its alloys for guaranteeing robust mechanical properties, are expected to reinforce and improve the stability of the vertebral columns, for example by promoting the fusion of two adjacent vertebras, or in replacing the natural disc. Unhappily, despite major progresses over the last decades, and the large use of potent antibiotics, up to 18% of the patients report a post-operatory infection at short or long term. Handicaps, pains and morbidity are only few of the complications resulting from infections. Moreover, the economic burden for the health system is tremendous, and estimated up to 900 k$ for each implant affected by infection. This project aims to prevent short (hours) and long (months) term infections. By combining the innovative advances in material science, nanostructured materials and biodegradable polymer coatings to develop controlled drug delivery of suitable elements allowing to counter effects the above mentioned infections in spinal implants. The expected results include the integration of the materials directly into bone, the limitation of inflammation, and to avoid the development of infection at short and medium terms, minutes to weeks after the implantations. Through this application to NSERC, we are proposing to complement this research (already funded by the FRQNT Team - Mantovani/Naccache at ULaval/Concordia from May 2020 to April 2023) with a study focused on the specific biological performance assessment by including Dr Fabio Variola team, from U of Ottawa.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
560903-2020
Name nom
Mantovani, Diego
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2000
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials science and technology
Research subject fr
Science et technologie des matériaux
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Design, development and validation of a tunable antibacterial coating for spinal implants: Focus on biological performances through the NSERC-FRQNT NOVA Complement. _x000d_ _x000d_
Keyword
NSERC
Application summary
Back pains are considered as the main cause of invalidity worldwide (Population Health Worldwide Statistic, 2018), which include minor disturbs (dorsal sprains) to normal wear of intervertebral discs or sciatic. Arthroses, as a disc degeneration, and osteoporosis, constitute the main cause of these clinical complications. Often treated early by manipulations, when the diseases progress, surgeries are which include the implantation of a rachis implant. Directly implanted into spine, evident challenges and clinical risks represent major factor to control for the success. These implants, made of Ti and its alloys for guaranteeing robust mechanical properties, are expected to reinforce and improve the stability of the vertebral columns, for example by promoting the fusion of two adjacent vertebras, or in replacing the natural disc. Unhappily, despite major progresses over the last decades, and the large use of potent antibiotics, up to 18% of the patients report a post-operatory infection at short or long term. Handicaps, pains and morbidity are only few of the complications resulting from infections. Moreover, the economic burden for the health system is tremendous, and estimated up to 900 k$ for each implant affected by infection. This project aims to prevent short (hours) and long (months) term infections. By combining the innovative advances in material science, nanostructured materials and biodegradable polymer coatings to develop controlled drug delivery of suitable elements allowing to counter effects the above mentioned infections in spinal implants. The expected results include the integration of the materials directly into bone, the limitation of inflammation, and to avoid the development of infection at short and medium terms, minutes to weeks after the implantations. Through this application to NSERC, we are proposing to complement this research (already funded by the FRQNT Team - Mantovani/Naccache at ULaval/Concordia from May 2020 to April 2023) with a study focused on the specific biological performance assessment by including Dr Fabio Variola team, from U of Ottawa.